bisoprolol has been researched along with Hyperthyroid in 5 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Excerpt | Relevance | Reference |
---|---|---|
"Nine hyperthyroid patients (FT4 greater than or equal to 20 ng/L; FT3 greater than or equal to 6 ng/L) were given 1 X 10 mg bisoprolol/day p." | 7.67 | Pharmacokinetics of bisoprolol and influence on serum thyroid hormones in hyperthyroid patients. ( Adam, W; Baew-Christow, T; Bux, B; Cordes, M; Disselhoff, G; Pabst, J; Panitz, N; Pfannenstiel, P; Rummeny, E, 1986) |
"Doppler-echocardiography was used to assess left ventricular (LV) structure and function, hemodynamics and total arterial stiffness in untreated overt hyperthyroid patients before and 2 h after 5 mg bisoprolol given orally compared with age- and sex-matched healthy euthyroid controls." | 5.11 | Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. ( Biondi, B; Fazio, S; Lombardi, G; Palmieri, EA; Palmieri, V, 2004) |
"Nine hyperthyroid patients (FT4 greater than or equal to 20 ng/L; FT3 greater than or equal to 6 ng/L) were given 1 X 10 mg bisoprolol/day p." | 3.67 | Pharmacokinetics of bisoprolol and influence on serum thyroid hormones in hyperthyroid patients. ( Adam, W; Baew-Christow, T; Bux, B; Cordes, M; Disselhoff, G; Pabst, J; Panitz, N; Pfannenstiel, P; Rummeny, E, 1986) |
"Hyperthyroidism is associated with low exercise tolerance despite high cardiac output and sometimes with the development of heart failure." | 1.33 | Genomic and non-genomic regulation of L-type calcium channels in rat ventricle by thyroid hormone. ( Aizawa, Y; Chinushi, M; Hatada, K; Hosaka, Y; Komura, S; Ma, M; Washizuka, T; Watanabe, H; Watanabe, K; Yamamoto, T; Yoshida, T, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Palmieri, EA | 2 |
Fazio, S | 1 |
Palmieri, V | 1 |
Lombardi, G | 2 |
Biondi, B | 2 |
Klain, M | 1 |
Schlumberger, M | 1 |
Filetti, S | 1 |
Watanabe, H | 1 |
Washizuka, T | 1 |
Komura, S | 1 |
Yoshida, T | 1 |
Hosaka, Y | 1 |
Hatada, K | 1 |
Aizawa, Y | 1 |
Chinushi, M | 1 |
Yamamoto, T | 1 |
Ma, M | 1 |
Watanabe, K | 1 |
Pfannenstiel, P | 1 |
Rummeny, E | 1 |
Baew-Christow, T | 1 |
Bux, B | 1 |
Cordes, M | 1 |
Adam, W | 1 |
Panitz, N | 1 |
Pabst, J | 1 |
Disselhoff, G | 1 |
Jungmann, E | 1 |
Rosak, C | 1 |
Schifferdecker, E | 1 |
Schumm-Draeger, PM | 1 |
Schöffling, K | 1 |
1 review available for bisoprolol and Hyperthyroid
Article | Year |
---|---|
Subclinical hyperthyroidism: clinical features and treatment options.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cardiovascular Diseases; Female; Humans; Hyperthyroid | 2005 |
2 trials available for bisoprolol and Hyperthyroid
Article | Year |
---|---|
Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Arteries; Biomechanical | 2004 |
[The cardioselective beta blocker bisoprolol. Value in the therapy of florid hyperthyroidism].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Carbimazole; Clinical Trials as Topic; Double- | 1986 |
2 other studies available for bisoprolol and Hyperthyroid
Article | Year |
---|---|
Genomic and non-genomic regulation of L-type calcium channels in rat ventricle by thyroid hormone.
Topics: Acetylcholine; Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Bisoprolol; Calcium Channels | 2005 |
Pharmacokinetics of bisoprolol and influence on serum thyroid hormones in hyperthyroid patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Blood Pressure; Female; Heart Rate; Humans; Hy | 1986 |